Emerging Paradigms in Insulin Resistance |
Autore | Burke Susan J |
Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (190 p.) |
Soggetto topico |
Research & information: general
Biology, life sciences |
Soggetto non controllato |
epicardial adipose tissue
hypertrophy of adipocytes CAD severity adipokines insulin resistance insulin-degrading enzyme pancreas liver insulin receptor glucose transporters acute intermittent porphyria carbohydrate loading therapy hyperinsulinemia fast-acting insulin experimental liver-targeted insulin hyperinsulinaemia osteocalcin beta-hydroxybutyrate phenotype stages serotonin glucagon-like peptide-1 glucagon type 2 diabetes hyperglycaemia apoptosis endoplasmic reticulum stress glucosamine pancreatic β-cell dysfunction ovariectomy raloxifene Negr1 obesity metabolic disease metabolomics glucose intolerance genetic models beta hydroxybutyrate osteoporosis fragility fractures bone mineral density osteocalin vitamin D collagen hydroxyapatite diabetes inflammation thiazolidinedione |
ISBN | 3-0365-5366-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910619471703321 |
Burke Susan J
![]() |
||
MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges |
Autore | Mager Hans-Jurgen |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (228 p.) |
Soggetto topico | Research & information: general |
Soggetto non controllato |
hereditary hemorrhagic telangiectasia
rare diseases telangiectasis transforming growth factor-beta (TGF-β) Smad pathway gastrointestinal bleeding epistaxis nosebleeds tacrolimus nasal ointment genetic disease rare disease hereditary hemorrhagic telangiectasia (HHT) telangiectases mechanical damage sun-induced trauma vascular malformations Endoglin activin-receptor-like kinase 1 Hereditary Hemorrhagic Telangiectasia antithrombotic therapy anticoagulants antiplatelets bleeding safety HHT ALK1 endoglin raloxifene bazedoxifene tranexamic acid propranolol FK506 etamsylate N-acetylcysteine pulmonary arteriovenous malformations transcatheter embolotherapy screening guidelines Hereditary hemorrhagic telangiectasia pediatrics genotype–phenotype correlation arteriovenous malformation ENG ACVRL1 SMAD4 microRNA biomarker plasma arteriovenous malformations (AVMs) angiogenesis activin receptor-like kinase 1 (ALK1) transforming growth factor beta (TGF-β) bone morphogenetic protein (BMP) propranolol gel epistaxis severity score nasal endoscopy antiangiogenic properties non-coding RNAs microRNAs long non-coding RNAs biomarkers endothelial cells hereditary hemorrhagic telangiectasia (HHT), second-hit arteriovenous malformation (AVM) Smad4 inflammation shear stress vascular injury somatic mutation cell adhesion vascular endothelial growth factor (VEGF) telangiectasia hereditary hemorrhagic survival life expectancy pulmonary arteriovenous malformation contrast enhanced magnetic resonance angiography liver MRI ultrasound AVM bevacizumab Osler–Weber–Rendu hereditary hemorrhagic telangiectasia/HHT/osler’s disease cerebral ischemic lesions catheter based embolization therapy |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Hereditary Hemorrhagic Telangiectasia |
Record Nr. | UNINA-9910557578003321 |
Mager Hans-Jurgen
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|